Platelet factor 4 inhibits FGF2-induced endothelial cell proliferation via the extracellular signal-regulated kinase pathway but not by the phosphatidylinositol 3-kinase pathway.

@article{Sulpice2002PlateletF4,
  title={Platelet factor 4 inhibits FGF2-induced endothelial cell proliferation via the extracellular signal-regulated kinase pathway but not by the phosphatidylinositol 3-kinase pathway.},
  author={Eric Sulpice and Marijke Bryckaert and Julie Lacour and J O Contreres and G{\'e}rard Tobelem},
  journal={Blood},
  year={2002},
  volume={100 9},
  pages={
          3087-94
        }
}
Platelet factor 4 (PF-4) is a member of the chemokine family with powerful antiangiogenic properties. The mechanism by which PF-4 inhibits endothelial cell proliferation is unclear. We investigated the effects of PF-4 on the intracellular signal transduction induced by basic fibroblast growth factor (FGF2). We found that PF-4 (10 microg/mL) inhibited the FGF2-induced proliferation of adrenal cortex capillary endothelial (ACE) cells. The inhibition of MEK1/2 (mitogen-activated protein kinase… 
View on PubMed
bloodjournal.org
62 Citations
Highly Influential Citations
2
Background Citations
18
Methods Citations
1
Results Citations
2

Figures and Tables from this paper

62 Citations

Citation Type

Citation Type

Platelet factor 4 disrupts the intracellular signalling cascade induced by vascular endothelial growth factor by both KDR dependent and independent mechanisms.
TLDR
The effects of PF-4 on the signalling events involved in the proliferation induced by V EGF(165), which binds heparin, and by VEGF(121), which does not are compared.
NT3 inhibits FGF2‐induced neural progenitor cell proliferation via the PI3K/GSK3 pathway
TLDR
It is found that NT3 inhibits both FGF2‐induced neurosphere growth and bromodeoxyuridine (BrdU) incorporation in a dose‐dependent manner, and experiments with anti‐NT3 antibody revealed that endogenous NT3 also plays a role in inhibiting FGF1‐induced NP cell proliferation, and that anti‐ NT3 antibody enhanced phospho‐Akt and phospho-GSK3β levels in the presence of FGF 2.
Fibroblast growth factor receptor‐1 mediates the inhibition of endothelial cell proliferation and the promotion of skeletal myoblast differentiation by SPARC: A role for protein kinase A
TLDR
SPARC modulates the mitogenic effect of FGF‐2 downstream from FGFR1 by selective regulation of the MAPK signaling cascade by activation of protein kinase A (PKA), a known regulator of Raf‐MAPK pathway.
CXCL4L1 and CXCL4 signaling in human lymphatic and microvascular endothelial cells and activated lymphocytes: involvement of mitogen-activated protein (MAP) kinases, Src and p70S6 kinase
TLDR
It is confirmed that the angiostatic chemokines CXCL4L1 and CxCL4 activate both CXCR3A and CX CR3B and bring new insights into the complexity of their signaling cascades.
F-Prostaglandin receptor regulates endothelial cell function via fibroblast growth factor-2
TLDR
A novel mechanism whereby epithelial prostaglandin F2α-FP signalling regulates endothelial cell network formation and proliferation is shown.
Tissue factor is involved in retinoblastoma cell proliferation via both the Akt and extracellular signal-regulated kinase pathways.
TLDR
It is demonstrated for the first time that TF is closely related to the proliferation of retinoblastoma cells, which could be therefore effectively suppressed by blockade of the TF pathway via TF pathway inhibitor (TFPI).
Molecular pathways of platelet factor 4/CXCL4 signaling.
Suppression of the Raf/MEK/ERK Signaling Cascade and Inhibition of Angiogenesis by the Carboxyl Terminus of Angiopoietin-Like Protein 4
TLDR
The carboxyl terminus of Angptl4 alone is sufficient to suppress angiogenesis, possibly through inhibiting the Raf/MEK/ERK1/2 MAP kinase pathway in endothelial cells.
Platelet factor 4 promotes adhesion of hematopoietic progenitor cells and binds IL-8: novel mechanisms for modulation of hematopoiesis.
TLDR
It is concluded that PF4 has the capacity to influence hematopoiesis through mechanisms not mediated by a classical high-affinity, 7-transmembrane domain chemokine receptor, and may modulate the heMatopoietic milieu both directly and indirectly by promoting progenitor adhesion and quiescence through interaction with an HPC chondroitin sulfate-containing moiety.
Platelet factor-4 (CXCL4/PF-4): an angiostatic chemokine for cancer therapy.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 54 REFERENCES
Inhibition of human umbilical vein endothelial cell proliferation by the CXC chemokine, platelet factor 4 (PF4), is associated with impaired downregulation of p21(Cip1/WAF1).
TLDR
Findings indicate that PF4 inhibition of HUVEC proliferation in response to EGF is associated with impaired downregulation of p21(Cip1/WAF1) and provide the first evidence for interference with cell cycle mechanisms by a chemokine.
PDGF and FGF-2 Signaling in Oligodendrocyte Progenitor Cells: Regulation of Proliferation and Differentiation by Multiple Intracellular Signaling Pathways
TLDR
The molecular mechanism that controls oligodendrocyte lineage progression is operated by at least two signal pathways, which interfere either with proliferation and/or differentiation of oligod endocrine progenitors.
cAMP‐dependent protein kinase inhibits the mitogenic action of vascular endothelial growth factor and fibroblast growth factor in capillary endothelial cells by blocking Raf activation
TLDR
It is demonstrated, in cultured endothelial cells, that the cAMP/PKA signaling pathway is potentially an important physiological inhibitor of mitogen activation of the MAPK cascade and cell proliferation.
Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization.
TLDR
Results indicate that PF-4 interacts with FGF-2 by complex formation, inhibiting F GF-2 dimerization, binding to FGF receptors, and internalization, which most likely contributes to the antiangiogenic properties ofPF-4.
Fibroblast growth factor 2 uses PLC-gamma1 for cell proliferation and PI3-kinase for alteration of cell shape and cell proliferation in corneal endothelial cells.
TLDR
Findings indicate that FGF-2 uses distinct and/or dual signaling pathways for individual biological activities, including stimulation of cell proliferation and cell shape change and induction of fibrillar collagen.
Proliferation of CECs requires dual signaling through both MAPK/ERK and PI 3-K/Akt pathways.
TLDR
It is demonstrated that PI 3-K signaling is a key component in cell proliferation can be demonstrated by controlling ERK activity, and may have major implications for developing more selective methods for antiangiogenic and antitumoral therapy.
cAMP-dependent protein kinase (PKA) inhibits T cell activation by phosphorylating ser-43 of raf-1 in the MAPK/ERK pathway.
Inhibitory effect of PGE2 on EGF-induced MAP kinase activity and rabbit corneal epithelial proliferation.
TLDR
EGF-induced increases in PGE2 production dampened the mitogenic response to this growth factor, indicating that the mitogens response to EGF in vivo in the proliferating basal cell layer may be dependent on the level of its PKA activity.
Inhibition of in vitro angiogenesis by platelet factor-4-derived peptides and mechanism of action.
TLDR
It is shown that a peptide between amino acids 47 and 70 that contains the heparin-binding lysine-rich site inhibits FGF-2 or VEGF function.
Inhibition of endothelial cell proliferation by platelet factor-4 involves a unique action on S phase progression
TLDR
A unique mode of endothelial cell growth inhibition is revealed whereby PF-4 effectively blocked cell cycle progression during S phase, demonstrating that in G0/G1-arrested cells,PF-4 inhibited entry of endothelium cells into S phase.
...
1
2
3
4
5
...